Opaleye Management’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-150,000
| Closed | -$1.84M | – | 56 |
|
|
2023
Q4 | $1.84M | Sell |
150,000
-350,000
| -70% | -$4.29M | 0.49% | 37 |
|
|
2023
Q3 | $4.82M | Sell |
500,000
-220,000
| -31% | -$2.12M | 1.57% | 15 |
|
|
2023
Q2 | $6.48M | Sell |
720,000
-203,200
| -22% | -$1.83M | 1.55% | 15 |
|
|
2023
Q1 | $7.26M | Hold |
923,200
| – | – | 2.17% | 13 |
|
|
2022
Q4 | $6.24M | Buy |
+923,200
| New | +$6.24M | 2.17% | 14 |
|
|
2021
Q1 | – | Sell |
-470,203
| Closed | -$8.93M | – | 62 |
|
|
2020
Q4 | $8.93M | Hold |
470,203
| – | – | 1.17% | 24 |
|
|
2020
Q3 | $5.86M | Buy |
470,203
+8,703
| +2% | +$109K | 1.15% | 32 |
|
|
2020
Q2 | $5.58M | Buy |
461,500
+236,500
| +105% | +$2.86M | 1.13% | 31 |
|
|
2020
Q1 | $1.72M | Buy |
+225,000
| New | +$1.72M | 0.46% | 38 |
|